nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Ileus paralytic—Vinorelbine—ovarian cancer	0.0723	0.0723	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Paclitaxel—ovarian cancer	0.0486	0.0486	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Paclitaxel—ovarian cancer	0.0429	0.0429	CcSEcCtD
Trihexyphenidyl—Asthenia—Altretamine—ovarian cancer	0.0296	0.0296	CcSEcCtD
Trihexyphenidyl—Dizziness—Altretamine—ovarian cancer	0.0272	0.0272	CcSEcCtD
Trihexyphenidyl—Vomiting—Altretamine—ovarian cancer	0.0262	0.0262	CcSEcCtD
Trihexyphenidyl—Nausea—Altretamine—ovarian cancer	0.0245	0.0245	CcSEcCtD
Trihexyphenidyl—Blindness—Epirubicin—ovarian cancer	0.0217	0.0217	CcSEcCtD
Trihexyphenidyl—Hallucination—Chlorambucil—ovarian cancer	0.0205	0.0205	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—ovarian cancer	0.0201	0.0201	CcSEcCtD
Trihexyphenidyl—Weight decreased—Vinorelbine—ovarian cancer	0.0177	0.0177	CcSEcCtD
Trihexyphenidyl—Agitation—Chlorambucil—ovarian cancer	0.0165	0.0165	CcSEcCtD
Trihexyphenidyl—Confusional state—Chlorambucil—ovarian cancer	0.0148	0.0148	CcSEcCtD
Trihexyphenidyl—Dry skin—Paclitaxel—ovarian cancer	0.014	0.014	CcSEcCtD
Trihexyphenidyl—Tachycardia—Melphalan—ovarian cancer	0.0125	0.0125	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Chlorambucil—ovarian cancer	0.0121	0.0121	CcSEcCtD
Trihexyphenidyl—Weight decreased—Paclitaxel—ovarian cancer	0.0119	0.0119	CcSEcCtD
Trihexyphenidyl—Dry skin—Docetaxel—ovarian cancer	0.0119	0.0119	CcSEcCtD
Trihexyphenidyl—Constipation—Topotecan—ovarian cancer	0.0111	0.0111	CcSEcCtD
Trihexyphenidyl—Tachycardia—Vinorelbine—ovarian cancer	0.0109	0.0109	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Topotecan—ovarian cancer	0.0107	0.0107	CcSEcCtD
Trihexyphenidyl—Asthenia—Chlorambucil—ovarian cancer	0.0105	0.0105	CcSEcCtD
Trihexyphenidyl—Weight decreased—Docetaxel—ovarian cancer	0.0101	0.0101	CcSEcCtD
Trihexyphenidyl—Constipation—Vinorelbine—ovarian cancer	0.00954	0.00954	CcSEcCtD
Trihexyphenidyl—Asthenia—Topotecan—ovarian cancer	0.00935	0.00935	CcSEcCtD
Trihexyphenidyl—Vomiting—Chlorambucil—ovarian cancer	0.00931	0.00931	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Vinorelbine—ovarian cancer	0.00919	0.00919	CcSEcCtD
Trihexyphenidyl—Asthenia—Melphalan—ovarian cancer	0.00916	0.00916	CcSEcCtD
Trihexyphenidyl—Tension—Paclitaxel—ovarian cancer	0.00902	0.00902	CcSEcCtD
Trihexyphenidyl—Nervousness—Paclitaxel—ovarian cancer	0.00893	0.00893	CcSEcCtD
Trihexyphenidyl—Nausea—Chlorambucil—ovarian cancer	0.0087	0.0087	CcSEcCtD
Trihexyphenidyl—Vision blurred—Paclitaxel—ovarian cancer	0.00866	0.00866	CcSEcCtD
Trihexyphenidyl—Dizziness—Topotecan—ovarian cancer	0.00862	0.00862	CcSEcCtD
Trihexyphenidyl—Agitation—Paclitaxel—ovarian cancer	0.00845	0.00845	CcSEcCtD
Trihexyphenidyl—Vomiting—Topotecan—ovarian cancer	0.00829	0.00829	CcSEcCtD
Trihexyphenidyl—Rash—Topotecan—ovarian cancer	0.00822	0.00822	CcSEcCtD
Trihexyphenidyl—Dermatitis—Topotecan—ovarian cancer	0.00821	0.00821	CcSEcCtD
Trihexyphenidyl—Headache—Topotecan—ovarian cancer	0.00817	0.00817	CcSEcCtD
Trihexyphenidyl—Vomiting—Melphalan—ovarian cancer	0.00812	0.00812	CcSEcCtD
Trihexyphenidyl—Rash—Melphalan—ovarian cancer	0.00805	0.00805	CcSEcCtD
Trihexyphenidyl—Dermatitis—Melphalan—ovarian cancer	0.00804	0.00804	CcSEcCtD
Trihexyphenidyl—Asthenia—Vinorelbine—ovarian cancer	0.008	0.008	CcSEcCtD
Trihexyphenidyl—Dry skin—Epirubicin—ovarian cancer	0.008	0.008	CcSEcCtD
Trihexyphenidyl—Nausea—Topotecan—ovarian cancer	0.00774	0.00774	CcSEcCtD
Trihexyphenidyl—Nausea—Melphalan—ovarian cancer	0.00758	0.00758	CcSEcCtD
Trihexyphenidyl—Confusional state—Paclitaxel—ovarian cancer	0.00756	0.00756	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—ovarian cancer	0.0074	0.0074	CcSEcCtD
Trihexyphenidyl—Dizziness—Vinorelbine—ovarian cancer	0.00737	0.00737	CcSEcCtD
Trihexyphenidyl—Tachycardia—Paclitaxel—ovarian cancer	0.00732	0.00732	CcSEcCtD
Trihexyphenidyl—Vomiting—Vinorelbine—ovarian cancer	0.00709	0.00709	CcSEcCtD
Trihexyphenidyl—Rash—Vinorelbine—ovarian cancer	0.00703	0.00703	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vinorelbine—ovarian cancer	0.00703	0.00703	CcSEcCtD
Trihexyphenidyl—Headache—Vinorelbine—ovarian cancer	0.00699	0.00699	CcSEcCtD
Trihexyphenidyl—Weight decreased—Epirubicin—ovarian cancer	0.00682	0.00682	CcSEcCtD
Trihexyphenidyl—Drowsiness—Epirubicin—ovarian cancer	0.00672	0.00672	CcSEcCtD
Trihexyphenidyl—Somnolence—Paclitaxel—ovarian cancer	0.00667	0.00667	CcSEcCtD
Trihexyphenidyl—Nausea—Vinorelbine—ovarian cancer	0.00662	0.00662	CcSEcCtD
Trihexyphenidyl—Constipation—Paclitaxel—ovarian cancer	0.00641	0.00641	CcSEcCtD
Trihexyphenidyl—Confusional state—Docetaxel—ovarian cancer	0.00641	0.00641	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—ovarian cancer	0.00631	0.00631	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—ovarian cancer	0.00622	0.00622	CcSEcCtD
Trihexyphenidyl—Tachycardia—Docetaxel—ovarian cancer	0.00621	0.00621	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Paclitaxel—ovarian cancer	0.00618	0.00618	CcSEcCtD
Trihexyphenidyl—Somnolence—Docetaxel—ovarian cancer	0.00565	0.00565	CcSEcCtD
Trihexyphenidyl—Constipation—Docetaxel—ovarian cancer	0.00544	0.00544	CcSEcCtD
Trihexyphenidyl—Asthenia—Paclitaxel—ovarian cancer	0.00538	0.00538	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Docetaxel—ovarian cancer	0.00524	0.00524	CcSEcCtD
Trihexyphenidyl—Tension—Epirubicin—ovarian cancer	0.00516	0.00516	CcSEcCtD
Trihexyphenidyl—Nervousness—Epirubicin—ovarian cancer	0.0051	0.0051	CcSEcCtD
Trihexyphenidyl—Dizziness—Paclitaxel—ovarian cancer	0.00496	0.00496	CcSEcCtD
Trihexyphenidyl—Vision blurred—Epirubicin—ovarian cancer	0.00495	0.00495	CcSEcCtD
Trihexyphenidyl—Agitation—Epirubicin—ovarian cancer	0.00483	0.00483	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—ovarian cancer	0.00477	0.00477	CcSEcCtD
Trihexyphenidyl—Vomiting—Paclitaxel—ovarian cancer	0.00477	0.00477	CcSEcCtD
Trihexyphenidyl—Rash—Paclitaxel—ovarian cancer	0.00473	0.00473	CcSEcCtD
Trihexyphenidyl—Dermatitis—Paclitaxel—ovarian cancer	0.00473	0.00473	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—ovarian cancer	0.00472	0.00472	CcSEcCtD
Trihexyphenidyl—Headache—Paclitaxel—ovarian cancer	0.0047	0.0047	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—ovarian cancer	0.00458	0.00458	CcSEcCtD
Trihexyphenidyl—Asthenia—Docetaxel—ovarian cancer	0.00456	0.00456	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—ovarian cancer	0.00447	0.00447	CcSEcCtD
Trihexyphenidyl—Nausea—Paclitaxel—ovarian cancer	0.00446	0.00446	CcSEcCtD
Trihexyphenidyl—Confusional state—Epirubicin—ovarian cancer	0.00432	0.00432	CcSEcCtD
Trihexyphenidyl—Dizziness—Docetaxel—ovarian cancer	0.0042	0.0042	CcSEcCtD
Trihexyphenidyl—Tachycardia—Epirubicin—ovarian cancer	0.00419	0.00419	CcSEcCtD
Trihexyphenidyl—Vomiting—Docetaxel—ovarian cancer	0.00404	0.00404	CcSEcCtD
Trihexyphenidyl—Rash—Docetaxel—ovarian cancer	0.00401	0.00401	CcSEcCtD
Trihexyphenidyl—Dermatitis—Docetaxel—ovarian cancer	0.00401	0.00401	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—ovarian cancer	0.004	0.004	CcSEcCtD
Trihexyphenidyl—Headache—Docetaxel—ovarian cancer	0.00398	0.00398	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—ovarian cancer	0.00387	0.00387	CcSEcCtD
Trihexyphenidyl—Somnolence—Epirubicin—ovarian cancer	0.00381	0.00381	CcSEcCtD
Trihexyphenidyl—Nausea—Docetaxel—ovarian cancer	0.00378	0.00378	CcSEcCtD
Trihexyphenidyl—Constipation—Epirubicin—ovarian cancer	0.00367	0.00367	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Epirubicin—ovarian cancer	0.00353	0.00353	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—ovarian cancer	0.00353	0.00353	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—ovarian cancer	0.00339	0.00339	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—ovarian cancer	0.00327	0.00327	CcSEcCtD
Trihexyphenidyl—Asthenia—Epirubicin—ovarian cancer	0.00308	0.00308	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxorubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Trihexyphenidyl—Dizziness—Epirubicin—ovarian cancer	0.00284	0.00284	CcSEcCtD
Trihexyphenidyl—Vomiting—Epirubicin—ovarian cancer	0.00273	0.00273	CcSEcCtD
Trihexyphenidyl—Rash—Epirubicin—ovarian cancer	0.0027	0.0027	CcSEcCtD
Trihexyphenidyl—Dermatitis—Epirubicin—ovarian cancer	0.0027	0.0027	CcSEcCtD
Trihexyphenidyl—Headache—Epirubicin—ovarian cancer	0.00269	0.00269	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—ovarian cancer	0.00262	0.00262	CcSEcCtD
Trihexyphenidyl—Nausea—Epirubicin—ovarian cancer	0.00255	0.00255	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—ovarian cancer	0.00252	0.00252	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—ovarian cancer	0.0025	0.0025	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—ovarian cancer	0.0025	0.0025	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—ovarian cancer	0.00249	0.00249	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—ovarian cancer	0.00236	0.00236	CcSEcCtD
